Prospettive Sociali e Sanitarie

Roland Vauth, Patrick W Corrigan, Martin Clauss, Margarete Dietl, Marlene Dreher-Rudolph, Rolf-Dieter Stieglitz,
and Rainer Vater
Cognitive Strategies Versus Self-Management Skills as Adjunct to Vocational Rehabilitation 55-66
Mark J Sergi, Robert S Kern, Jim Mintz, and Michael F Green
Learning Potential and the Prediction of Work Skill Acquisition in Schizophrenia 67-72
Steven M Silverstein, Charles J Wallace, and Lindsay S Schenkel
The Micro-Module Learning Tests: Work-Sample Assessments of Responsiveness to Skills Training 73-83
Judy L Thompson, John R Watson, Stuart R Steinhauer, Gerald Goldstein, and Michael F Pogue-Geile
Indicators of Genetic Liability to Schizophrenia: A Sibling Study of Neuropsychological Performance 85-96
Alexander T Sack, Vincent G van de Ven, Simone Etschenberg, Dietmar Schatz, and David E. J Linden
Enhanced vividness of mental imagery as a trait marker of schizophrenia? 97-104
Joselyn L Sellen, Mike Oaksford, and Nicola S Gray
Schizotypy and Conditional Reasoning 105-116
Martin Sarter, Christopher L Nelson, and John P Bruno
Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia 117-138
R E Lubow
Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia 139-153
Claudia I Rupp, W. Wolfgang Fleischhacker, Georg Kemmler, Harald Oberbauer, Arne W Scholtz, Caroline Wanko,
and Hartmann Hinterhuber
Various Bilateral Olfactory Deficits in Male Patients With Schizophrenia 155-165
Matthew M Kurtz, Paul J Moberg, J Daniel Ragland, Ruben C Gur, and Raquel E Gur
Symptoms Versus Neurocognitive Test Performance as Predictors of Psychosocial Status in Schizophrenia: A 1- and 4-
Year Prospective Study 167-174
Christopher R Bowie, Mark R Serper, Silvana Riggio, and Philip D Harvey
Neurocognition, Symptomatology, and Functional Skills in Older Alcohol-Abusing Schizophrenia Patients 175-182;
Schizophrenia bulletin, no 2, vol 31, 2005
Abstracts
Special Issue: Abstracts of the XX International Congress on Schizophrenia Research 183-605;
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .185
1. Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .187
2. Phenomenology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .195
3. Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .215
4. Neuroanatomy, Animal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .245
5. Neuropathology, Biochemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .248
6. Neuropathology, Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .257
7. Genetics, Clinical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .264
8. Genetics, Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .281
9. Neurochemistry, Clinical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .287
10. Neurochemistry, Animal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .295
11. Psychology, Neuro- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .315
12. Psychology, Cognitive . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .348
13. Neuroimaging, Structural . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .382
14. Neuroimaging, Functional . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .410
15. Neuroimaging, Neurochemical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .442
16. Electrophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .449
17. Eye Movement Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .469
18. Therapeutics: Treatment Trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .474
19. Therapeutics: Pharmacologic Probes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .509